Preview

Experimental and Clinical Gastroenterology

Advanced search

Wilson’s disease: a review of clinical guidelines, literature and a case report

https://doi.org/10.31146/1682-8658-ecg-203-7-239-245

Abstract

Wilson’s disease (hepatocerebral dystrophy) is a rare hereditary disease that is caused by impaired copper metabolism affecting many organs, but mainly the liver and nervous system. Interest in the problem does not subside, because diagnosis and management of patients presents certain difficulties. The article highlights the literature data, clinical recommendations when discussing their own clinical observation of two patients (brother and sister) in whom the disease was diagnosed in childhood. Presented are clinical data, dynamics of laboratory parameters during 15 years of follow-up against the background of adequate chelation therapy with D-penicylamine and zinc sulfate, as well as during interruption of treatment. The necessity of adherence to a lifelong regimen of therapy is emphasized, since it is this tactic that demonstrates effectiveness in improving the prognosis of the disease.

About the Authors

Elena V. Luzina
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation


Olga N. Yemelyanova
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation


Vladimir A. Shcherbak
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation


Larisa V. Fyodorova
Chita Regional Clinical Hospital
Russian Federation


Natalia N. Borovik
Chita Regional Children’s Clinical Hospital
Russian Federation


References

1. Narusheniya obmena medi (bolezn’ Vil’sona). Klinicheskie rekomendacii [Disorders of copper metabolism (Wilson’s disease. Clinical guidelines]. (in Russ.) Available at: https://cr.minzdrav.gov.ru/schema/376_2/ (accessed 21 January 2022) @@Нарушения обмена меди (болезнь Вильсона). Клинические рекомендации. Доступно на: https://cr.minzdrav.gov.ru/schema/376_2/ Доступ 21.01.2022

2. Członkowska A., Litwin T., Dusek P., et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21. Published 2018 Sep 6. doi:10.1038/s41572-018-0018-3

3. EASL Clinical Practice Guidelines: Wilson’s disease. Journal of Hepatology. 2012; 56(3): 671-685. doi:10.1016/j.jhep.2011.11.007.

4. Konovalov N. V. Gepatolentikulyarnaya distrofiya [Hepatolenticular dystrophy]. Moscow, Medgiz Publ., 1960. 556 p. (in Russ.). @@Коновалов Н. В. Гепатолентикулярная дистрофия. М.: Медгиз; 1960. 556 с.

5. Yuan X-Z., Yang R-M., Wang X-P. Management Perspective of Wilson’s Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol. 2021; 19(4): 465-485. doi:10.2174/1570159X18666200429233517

6. Ferenci P., Саса К., Loudianos G., et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139-42. doi:10.1034/j.1600-0676.2003.00824.x

7. Kozlova N.M., Gvak K. V., Gadzhibalayeva L. S. Wilson’s disease. Sibirskij medicinskij žurnal. 2011; 5: 125-129. (in Russ.)@@Козлова Н. М., Гвак К. В., Гаджибалаева Л. Ш. Болезнь Вильсона-Коновалова. Сибирский медицинский журнал (Иркутск). 2011; 5: 125-129.

8. Poleshchuk V.V., Fedotova E. Yu., Ivanova-Smolenskaya I. A. Sluchaj gepatolentikulyarnoj degeneracii s debyutom nevrologicheskoj formy posle 45 let [A case of hepatolenticular degeneration with the onset of a neurological form after 45 years]. Nervnye bolezni - Nervous diseases. 2012; 2: 40-44. (in Russ.)@@Полещук В. В., Федотова Е. Ю., Иванова-Смоленская И. А. Случай гепатолентикулярной дегенерации с дебютом неврологической формы после 45 лет. Нервные болезни. 2012; 2: 40-44.

9. Khlynova O.V., Stepina E. A., Vorobyeva N. N., et al. “Wilson’s crisis” in a 17-year-old patient. Farmateka. 2021; 2: 110-114. (in Russ.) doi: 10.18565/pharmateca.2021.2.110-114@@Хлынова О. В., Степина Е. А., Воробьева Н. Н. и др. «Вильсоновский криз» у 17-летней пациентки. Фарматека. 2021; 2: 110-114. doi: 10.18565/pharmateca.2021.2.110-114

10. Ignatova T.M., Solov’eva O.V., Arion E. A., Balashova M. S., Rozina T. P. Wilson - Konovalov’s disease in two sisters: differences in the clinical picture and successful therapy. Klin. med. 2016; 94 (1): 70-73. (in Russ.) doi:10.18821/0023-2149-2016-94-1-70-73 @@Игнатова Т. М., Соловьева О. В., Арион Е. А. и др. Болезнь Вильсона-Коновалова у двух сестер: различия клинического течения болезни, успешная терапия. Клиническая медицина. 2016; 94 (1): 70-73. doi:10.18821/0023-2149-2016-94-1-70-73

11. Kasztelan-Szczerbinska B., Cichoz-Lach H. Wilson’s Disease: An Update on the Diagnostic Workup and Management. J Clin Med. 2021; 10(21): 5097. doi:10.3390/jcm10215097

12. Kumar N., Prashant L. K., Goyal V. Wilson’s Disease Update: An Indian Perspective. Ann Indian Acad Neurol. 2021; 24(5): 652-663. doi:10.4103/aian.AIAN_171_21

13. Xie J-J., Wu Z-Y. Wilson’s Disease in China. Neurosci Bull. 2017; 33(3): 323-330. doi:10.1007/s12264-017-0107-4

14. Baiazutdinova G. M., Shchagina O. A., Poliakov A. V. The study of common mutation p.H1069Q in АТР7В gene in Russian WD-patients. Medical Genetics. 2018; 17(4): 25-30. (in Russ.) doi:10.25557/2073-7998.2018.04.25-30 @@Баязутдинова Г. М., Щагина О. А., Поляков А. В. Мутация с. 3207C>A гена ATP7B - наиболее частая причина гепатолентикулярной дегенерации в России: частота и причина распространения. Медицинская генетика. 2018;17(4):25-30. doi:10.25557/2073-7998.2018.04.25-30

15. Hermann W. Classification and differential diagnosis of Wilson’s disease. Ann Transl Med. 2019; 7(Suppl 2): S63. doi: 10.21037/atm.2019.02.07

16. Roberts E.A., Schilsky M. L. Diagnosis and treatment of Wilson disease: An update. Hepatology. 2008; 47: 2089-2111.

17. Golovanova E.V., Lazebnik L. B., Konev Y. V., Shaposhnikova N. A. [Wilson’s disease (hepatolenticular degeneration, dystrophia hepatocerebralis) diagnosis, treatment and dispensary observation. Guidelines were approved by the XV Gastroenterological Scientific Society of Russia in 2015]. Eksp Klin Gastroenterol. 2015;(7):108-111. (in Russ.) @@Голованова Е. В., Лазебник Л. Б., Конев Ю. В., Шапошникова Н. А. Болезнь Вильсона-Коновалова (гепатоцеребральная дистрофия, гепатолентикулярная дегенерация): диагностика, лечение и диспансерное наблюдение. Экспериментальная и клиническая гастроэнтерология. 2015; 119(7): 108-111.

18. Lucena-Valera A., Perez-Palacios D., Muñoz-Hernandez R., et al. Wilson’s disease: Revisiting an old friend. World J Hepatol. 2021; 13(6): 634-649. doi:10.4254/wjh.v13.i6.634

19. Maselbas W., Chabik G., Członkowska A. Persistence with treatment in patients with Wilson disease. Neurol Neurochir Pol. 2010;44(3):260-3. doi:10.1016/s0028-3843(14)60040-2

20. Dzieżyc K., Karliński M., Litwin T., Członkowska A.Compliant treatment with anti-copper agents prevents clinically overt Wilson’s disease in pre-symptomatic patients. Eur J Neurol. 2014;21(2):332-7. doi:10.1111/ene.12320


Review

For citations:


Luzina E.V., Yemelyanova O.N., Shcherbak V.A., Fyodorova L.V., Borovik N.N. Wilson’s disease: a review of clinical guidelines, literature and a case report. Experimental and Clinical Gastroenterology. 2022;(7):239-245. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-203-7-239-245

Views: 2862


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)